Robert Azelby Insider Trading
Get free email notifications about insider trading for Robert Azelby.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Azelby. Robert Azelby is a Director in IMMUNOMEDICS INC ($IMMU) and a Director in Cascadian Therapeutics, Inc. ($CASC) and a President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Director in Clovis Oncology, Inc. ($CLVS) and a EVP & Chief Commercial Officer in Juno Therapeutics, Inc. ($JUNO) and a See Remarks in Juno Therapeutics, Inc. ($JUNO).
Address: 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE 98109 WA
Companies in which Robert Azelby is an Insider
ALDER BIOPHARMACEUTICALS INC
Trading Symbol: ALDRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Azelby: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2019
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Trading Symbol: CASCIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Robert Azelby: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Azelby: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNOMEDICS INC
Trading Symbol: IMMUIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Robert Azelby: Director
Holdings: 3,718 shares
Current Value: $15,727
Latest Transaction: Jun 22 2020
$IMMU Market Capitalization: $442.84M
$IMMU Previous Close: $4.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Juno Therapeutics, Inc.
Trading Symbol: JUNOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robert Azelby: EVP & Chief Commercial Officer, See Remarks
Holdings: 82,112 shares
Current Value: $1,704,645
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert Azelby
Sentiment: All, ALDR, CASC, CLVS, IMMU, JUNO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Grant | A | 0.00 | 3,718 | 0 | 3,718 | 0 to 3.7 K |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Feb 27 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Option Exercise | A | 16.36 | 22,500 | 368,100 | 22,500 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | D | 16.20 | 150,000 | 2,430,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | D | 0.00 | 15,000 | 0 | 0 |